Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3β/β-Catenin Signaling Pathway

• Published in: Molecular neurobiology 2018-02, Vol.55 (2), p.1607-1619
• Main Authors: Kim, Sasuk, Lim, Juhee, Bang, Yeojin, Moon, Jisook, Kwon, Min-Soo, Hong, Jin Tae, Jeon, Jeha, Seo, Hyemyung, Choi, Hyun Jin
• Format: Article
• Language: English
• Subjects: alpha-Synuclein - metabolism; Axonogenesis; beta Catenin - metabolism; Biomedical and Life Sciences; Biomedicine; Cell Biology; Cell differentiation; Cell Differentiation - drug effects; Cell Line, Tumor; Disease transmission; Dopamine Plasma Membrane Transport Proteins - metabolism; Dopamine receptors; Dopamine transporter; Glycogen; Glycogen synthase kinase 3; Glycogen Synthase Kinase 3 beta - metabolism; Humans; Hydroxylase; Inactivation; Kinases; Mesencephalon; Mice; Missense mutation; Neurites - drug effects; Neurites - metabolism; Neurobiology; Neurodegenerative diseases; Neurology; Neuromodulation; Neurons; Neurons - drug effects; Neurons - metabolism; Neurosciences; Parkinson's disease; Phenotypes; Phosphatase; Phosphoprotein phosphatase; Protein phosphatase; Protein-tyrosine-phosphatase; Retinoic acid; Rodents; Signal transduction; Signal Transduction - drug effects; Synaptic transmission; Synaptogenesis; Synuclein; Tau protein; Transgenic animals; Transgenic mice; Tretinoin - pharmacology; Tyrosine 3-monooxygenase; Tyrosine 3-Monooxygenase - metabolism; Up-Regulation - drug effects; β-Catenin
• ISSN: 0893-7648; 1559-1182; 1559-1182
• DOI: 10.1007/s12035-016-0370-9

Alpha-synuclein (α-SYN) is expressed during neuronal development and is mainly involved in the modulation of synaptic transmission. Missense mutations and amplifications of this gene have been associated with the pathogenesis of Parkinson’s disease. Here, we evaluate whether α-SYN plays a detrimental role in the phenotypic and morphological regulation of neurons. We also identify the underlying mechanisms of this process in all- trans -retinoic acid (RA)-induced differentiated SH-SY5Y cells, which represents dopaminergic (DAergic) phenotype. Our results indicate that overexpression of wild-type or mutant A53T α-SYN attenuated the RA-induced upregulation of tyrosine hydroxylase and dopamine transporter as well as neurite outgrowth in SH-SY5Y cells. In addition, GSK-3β inactivation and downstream β-catenin stabilization were associated with RA-induced differentiation, which was attenuated by α-SYN. Moreover, protein phosphatase 2A was positively regulated by α-SYN and was implicated in the α-SYN-mediated interference with RA signaling. The results obtained from SH-SY5Y cells were verified in primary cultures of mesencephalic DAergic neurons from A53T α-SYN transgenic mice, which represent high levels of α-SYN and protein phosphatase 2A in the midbrain. The number and length of neurites in tyrosine hydroxylase-positive as well as Tau-positive cells from A53T α-SYN transgenic mice were significantly lower than those in littermate controls. The current results provide novel insight into the role of α-SYN in the regulation of neuronal differentiation, including DAergic neurons. Identifying the signaling pathway involved in the α-SYN-mediated dysregulation of neuronal differentiation could lead to a better understanding of the developmental processes underlying α-SYN-related pathologies and facilitate the discovery of specifically targeted therapeutics.